Apoptosis contributes to the regulation of cell growth and regeneration and to the development of neoplasia. Mcl-1 is an anti-apoptotic protein that is particularly important for the development of hematological and biliary malignancies, but the mechanism of action of Mcl-1 is unknown. Apoptosis can result from a range of extracellular or intracellular stimuli, which converge with activation of caspases to lead directly to cell death (1). Apoptosis provides a key control mechanism for the regulation of cell proliferation, differentiation and regeneration, and resistance to apoptosis has been linked to the development of neoplasia (2). Two general pathways to apoptosis have been described. One pathway is the so-called extrinsic pathway initiated by death receptors of the tumor necrosis factor receptor superfamily (3). The second pathway is the intrinsic pathway, which involves the convergence of intracellular stress signals on mitochondria resulting in mitochondrial permeability (4). In many cells, the death receptor pathway may also trigger mitochondrial dysfunction via caspase-mediated cleavage of the pro-apoptotic molecule, Bid, which when cleaved translocates to mitochondria triggering their permeabilization (5). In this respect, mitochondrial permeabilization is key to both pathways. Mitochondrial permeabilization results in release of cytochrome c into the cytosol, which then exhibits specific toxic effects (6, 7). Apoptosis via the mitochondrial pathway is inhibited by members of the Bcl-2 family of proteins, which includes Bcl-2, Bcl-x L , and Mcl-1 (8 -10). Bcl-2 inhibits apoptosis in part by decreasing the size of Ca 2ϩ stores in the endoplasmic reticulum (ER) 2 (11), whereas Bcl-x L acts in part by inhibiting expression of the inositol 1,4,5-trisphosphate (InsP 3 ) receptor (InsP 3 R) (12), which is the principal ER Ca 2ϩ release channel in most types of cells. Mcl-1 (myeloid cell leukemia-1) was first identified because this gene is up-regulated early in the differentiation of the ML-1 human myeloid leukemia cell line and was found to be a member of the emerging Bcl-2 gene family as well (13). However, the mechanism by which Mcl-1 inhibits apoptosis is not entirely understood. Because Mcl-1 is a member of the Bcl-2 family, we examined the effects of this protein on Ca 2ϩ signaling pathways.
EXPERIMENTAL PROCEDURESMaterials, Reagents, and Cell Lines-The Ca 2ϩ dyes fluo-4, magfluo-4, and rhod-2, the mitochondrial dye MitoTracker green, and the nuclear stain TO-PRO-3 were from Molecular Probes (Eugene, OR). JC-1, ATP, and staurosporine were from Sigma. A monoclonal antibody labeling the N-terminal region of the human type III InsP 3 R was from BD Transduction Laboratories (Lexington, KY) (14). A polyclonal antibody for Mcl-1 was from Santa Cruz Biotechnology (Santa Cruz, CA). A monoclonal antibody for the 17-kDa subunit of oxidative phosphorylation complex I, which is localized to mitochondria, was from Molecular Probes. The secondary antibodies were Alexa 488 anti-rabbit, Alexa 568 anti-mouse, and Alexa...